Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury

Fig. 3

Hemolytic activity of nanoparticles. a Red blood cells from healthy SD rats were incubated with 500 µg/mL of concentration of TMP.HCl, TMP-NPs, TAT-TMP-NPs, and Blank-NPs with saline as negative and RIPA as positive controls. b Hemolytic activity of different concentrations of various nanoparticle formulations. Values were expressed as mean ± standard deviation (n = 5). ANOVA was used to assess the statistical differences between groups. Symbols represented statistical significance of the labeled groups with group of TMP.HCl (#P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001)

Back to article page